SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Crinetics Pharmaceuticals Q1 EPS $(0.710) Down From $(0.370) YoY, Sales $71.000K Down From $367.000K YoY

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.710) per share. This is a 91.89 percent decrease over losses of $(0.370) per share from the same period last year. The company reported $71.000

Benzinga · 05/08/2020 13:07

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.710) per share. This is a 91.89 percent decrease over losses of $(0.370) per share from the same period last year. The company reported $71.000 thousand in sales this quarter. This is a 80.65 percent decrease over sales of $367.000 thousand the same period last year.